Intended use: For the quantitative determination of Antithrombin in human citrated plasma on the IL Coagulation systems.
Principle: Based on a synthetic chromogenic substrate and on FXa inactivation.
Measurement principle
AT + Heparin
[AT • Heparin]
[AT • Heparin] + FXa (excess) [AT • Heparin • FXa] + FXa (residual)
S-2765 + FXa (residual) Peptide + pNA
Vials and volumes:
- 2 x 2.5 mL Factor Xa reagent (lyo)
- 2 x 2 mL Chromogenic Substrate S-2765 (lyo)
*ACL, HemosIL and IL Tests are trademarks of Instrumentation Laboratory.
Life Science Research
